chr7-56011754-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_004577.4(PSPH):c.*8T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00142 in 1,599,934 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0070 ( 9 hom., cov: 31)
Exomes 𝑓: 0.00083 ( 14 hom. )
Consequence
PSPH
NM_004577.4 3_prime_UTR
NM_004577.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.62
Genes affected
PSPH (HGNC:9577): (phosphoserine phosphatase) The protein encoded by this gene belongs to a subfamily of the phosphotransferases. This encoded enzyme is responsible for the third and last step in L-serine formation. It catalyzes magnesium-dependent hydrolysis of L-phosphoserine and is also involved in an exchange reaction between L-serine and L-phosphoserine. Deficiency of this protein is thought to be linked to Williams syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 7-56011754-A-G is Benign according to our data. Variant chr7-56011754-A-G is described in ClinVar as [Benign]. Clinvar id is 910292.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00696 (1060/152242) while in subpopulation AFR AF= 0.023 (954/41536). AF 95% confidence interval is 0.0218. There are 9 homozygotes in gnomad4. There are 538 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PSPH | NM_004577.4 | c.*8T>C | 3_prime_UTR_variant | 8/8 | ENST00000275605.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PSPH | ENST00000275605.8 | c.*8T>C | 3_prime_UTR_variant | 8/8 | 1 | NM_004577.4 | P1 | ||
PSPH | ENST00000395471.7 | c.*8T>C | 3_prime_UTR_variant | 8/8 | 1 | P1 | |||
PSPH | ENST00000459834.5 | n.476T>C | non_coding_transcript_exon_variant | 3/3 | 3 | ||||
PSPH | ENST00000437355.6 | c.*8T>C | 3_prime_UTR_variant, NMD_transcript_variant | 6/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00695 AC: 1057AN: 152124Hom.: 9 Cov.: 31
GnomAD3 genomes
AF:
AC:
1057
AN:
152124
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00193 AC: 484AN: 251132Hom.: 4 AF XY: 0.00161 AC XY: 218AN XY: 135746
GnomAD3 exomes
AF:
AC:
484
AN:
251132
Hom.:
AF XY:
AC XY:
218
AN XY:
135746
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000833 AC: 1206AN: 1447692Hom.: 14 Cov.: 29 AF XY: 0.000776 AC XY: 560AN XY: 721186
GnomAD4 exome
AF:
AC:
1206
AN:
1447692
Hom.:
Cov.:
29
AF XY:
AC XY:
560
AN XY:
721186
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00696 AC: 1060AN: 152242Hom.: 9 Cov.: 31 AF XY: 0.00723 AC XY: 538AN XY: 74446
GnomAD4 genome
AF:
AC:
1060
AN:
152242
Hom.:
Cov.:
31
AF XY:
AC XY:
538
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Deficiency of phosphoserine phosphatase Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at